With nearly 20 percent of U.S. adults affected by depression, the prevalence of this mental health condition drives many to explore relief from its most challenging symptoms. A recent study offers ...

Mave Health is listing the headset at $495 for pre-orders. It aims to ship devices to users in the U.S. and India in April 2026.

For years, a small group of technology enthusiasts have been applying gentle electrical current to their brains in an effort to gain cognitive benefits, improve sleep, or aid memory. While brain ...

Home-based transcranial direct current stimulation (tDCS) with real-time remote supervision was associated with significantly greater symptom improvement and higher clinical remission rates than sham ...

Unsupervised, at-home use of transcranial direct current stimulation (tDCS) was no better than a sham control for treating a major depressive episode, a randomized trial showed. The PSYLECT trial of ...

Depression affects approximately 280 million people all over the world, and disproportionately affects the female population — it is 50% more common in women than men. Treatments range from ...

When added to stable selective serotonin reuptake inhibitors (SSRI) treatment, transcranial direct current stimulation (tDCS) was not superior to sham stimulation for major depressive disorder (MDD), ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...